日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA).

托珠单抗治疗 COVID-19 肺炎住院患者:一项随机对照试验的疗效、安全性、病毒清除率和抗体反应 (COVACTA)

Rosas Ivan O, Bräu Norbert, Waters Michael, Go Ronaldo C, Malhotra Atul, Hunter Bradley D, Bhagani Sanjay, Skiest Daniel, Savic Sinisa, Douglas Ivor S, Garcia-Diaz Julia, Aziz Mariam S, Cooper Nichola, Youngstein Taryn, Sorbo Lorenzo Del, Zerda David J De La, Ustianowski Andrew, Gracian Antonio Cubillo, Blyth Kevin G, Carratalà Jordi, François Bruno, Benfield Thomas, Haslem Derrick, Bonfanti Paolo, van der Leest Cor H, Rohatgi Nidhi, Wiese Lothar, Luyt Charles Edouard, Bauer Rebecca N, Cai Fang, Lee Ivan T, Matharu Balpreet, Metcalf Louis, Wildum Steffen, Graham Emily, Tsai Larry, Bao Min

Analysis of origin, risk factors influencing COVID-19 cases in India and its prediction using ensemble learning

利用集成学习分析印度新冠肺炎病例的起源、风险因素及其预测

Rosas, Ivan O; Bräu, Norbert; Waters, Michael; Go, Ronaldo C; Hunter, Bradley D; Bhagani, Sanjay; Skiest, Daniel; Aziz, Mariam S; Cooper, Nichola; Douglas, Ivor S; Savic, Sinisa; Youngstein, Taryn; Del Sorbo, Lorenzo; Cubillo Gracian, Antonio; De La Zerda, David J; Ustianowski, Andrew; Bao, Min; Dimonaco, Sophie; Graham, Emily; Matharu, Balpreet; Spotswood, Helen; Tsai, Larry; Malhotra, Atul; Rajesh, N; Christodoss, Prasanna Ranjith

Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children: A Randomized, Double-blind, Active Controlled Phase 3 Safety and Efficacy Trial (miniSTONE-2)

巴洛沙韦酯单剂量治疗流感感染儿童:一项随机、双盲、活性对照的3期安全性和有效性试验(miniSTONE-2)

Baker, Jeffrey; Block, Stanley L; Matharu, Balpreet; Burleigh Macutkiewicz, Laura; Wildum, Steffen; Dimonaco, Sophie; Collinson, Neil; Clinch, Barry; Piedra, Pedro A